Dr. Luke Norton, PhD
Claim this profileClinical Trials Luke Norton, PhD is currently running
More about Luke Norton, PhD
Clinical Trial Related
3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Luke Norton, PhD has experience with
- Pioglitazone
- Placebo
Breakdown of trials Luke Norton, PhD has run
Nonalcoholic Steatohepatitis
Non-alcoholic Fatty Liver Disease
Mitochondrial disease
Motor Skills
Type 2 Diabetes
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Luke Norton, PhD specialize in?
Luke Norton, PhD focuses on Nonalcoholic Steatohepatitis and Non-alcoholic Fatty Liver Disease. In particular, much of their work with Nonalcoholic Steatohepatitis has involved treating patients, or patients who are undergoing treatment.
Is Luke Norton, PhD currently recruiting for clinical trials?
Yes, Luke Norton, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Luke Norton, PhD has studied deeply?
Yes, Luke Norton, PhD has studied treatments such as Pioglitazone, Placebo.
What is the best way to schedule an appointment with Luke Norton, PhD?
Apply for one of the trials that Luke Norton, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.